We sold Australian-based testing, inspection, and certification company ALS Limited (ASX:ALQ) at a loss after owning it for just over a year. The company announced a rights issue, which we thought was unnecessary, at a steep discount to market price. This decreased both our appraisal and confidence in management’s capital allocation skill.
From Longleaf Partners' International Fund first quarter 2016 letter.
